Drug to Drug Interaction Study With Ipragliflozin and Furosemide

Clinical trial NCT01611415 · COMPLETED

Trial details

NCT number: NCT01611415
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics of Ipragliflozin

Start date: 2011-07-01
Primary completion: 2011-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.